Page 384 - IJB-9-4
P. 384

International Journal of Bioprinting                                             Evolution of bioprinting



            which each should  be used,  which is to ensure good   Author contributions
            mechanical properties and high cell viability at the same   Conceptualization:  Jesús M. Rodríguez-Rego, Laura
            time. In the future, these discoveries will make it possible   Mendoza-Cerezo
            to reduce printing time while increasing cell viability, as   Funding acquisition: Alfonso C. Marcos-Romero
            well as increasing the resemblance of bioprinted tissues to   Investigation: Jesús M. Rodríguez-Rego, Laura Mendoza-
            real tissues of the organism.
                                                                  Cerezo
            5. Conclusion                                      Project administration:  Alfonso C. Marcos-Romero,
            Bioprinting is developing at an exponential rate, with new   Antonio Macías-García
            and important discoveries being made every day. With the   Supervision:  Antonio Macías-García, Antonio Díaz-
            research on bioprinting first published in 1998 when the   Parralejo
            term “bioprinting” had not yet been coined, and with the   Writing – original draft: Laura Mendoza-Cerezo
            publication of only very few articles in the following years,   Writing – review & editing:  Jesús  M.  Rodríguez-Rego,
            the humble start of bioprinting research has gradually piqued   Alfonso C. Marcos-Romero
            the interest of the scientific community, and the tremendous
            exploration of this technique has eventually generated   Ethics approval and consent to participate
            more than 1000 publications in each of the last 2 years. It is   Not applicable.
            anticipated that, in a matter of a few years, it will undergo
            another round of evolution, accompanied by more impactful   Consent for publication
            and beneficial applications. Moreover, it is also expected
            that bioprinting will be applied in medical regeneration, as a   Not applicable.
            routine practice in hospitals and laboratories.

               Great successes of bioprinting, such as  in situ   Availability of data
            reconstruction of tissues on the patient that led to excellent   Not applicable.
            outcomes in skin regeneration , reconstruction of
                                       [94]
            ovarian tissue that allows the gestation of offspring in a   References
            natural way , reconstruction of a thyroid gland capable
                     [79]
            of normalizing thyroxine levels in the blood , and   1.   Ozbolat IT, Yu Y, 2013, Bioprinting toward organ fabrication:
                                                    [81]
            regeneration of damaged axons of a spinal cord , are   Challenges and future trends. IEEE Trans Biomed Eng, 60(3):
                                                     [92]
            all indicators that the continued evolution of bioprinting   691–699.
            will eventually aid in the development of new therapies,   http://doi.org/10.1109/TBME.2013.2243912.
            such as the generation of complete organs for autologous   2.   Park  A, Wu  B, Griffith LG,  1998,  Integration of surface
            transplants and the new solutions to currently incurable   modification and 3D fabrication techniques to prepare
            diseases. This also corroborates the fact that bioprinting   patterned poly(L-lactide) substrates allowing regionally
            is an impetus to the revolution in modern medicine,   selective cell adhesion. J Biomater Sci Polym Ed, 9(2): 89–110.
            thanks to current and future advances as well as any new   http://doi.org/10.1163/156856298X00451.
            applications that are yet to be discovered or conceived.
                                                               3.   Kim SS, Utsunomiya H, Koksi JA,  et al., 1998, Survival
            Acknowledgments                                       and function of hepatocytes on a novel three-dimensional
                                                                  synthetic biodegradable polymer scaffold with an intrinsic
            We want to thank the European Regional Development    network of channels. Ann Surg, 228(1): 8.
            Fund (ERDF) in the framework of the project           http://doi.org/10.1097/00000658-199807000-00002.
            (BIOSIMPRO. IB20158) with the code 2021/00110/001 for
            funding this publication.                          4.   Bhatia SN, Chen CS, 1999, Tissue engineering at the micro-
                                                                  scale. Biomed Microdevices, 2(2): 131–144.
            Funding                                               http://doi.org/10.1023/A:1009949704750.
            This work was funded by the European Regional      5.   Vozzi G, Ahluwalia A, de Rossi D, et al., 2000, Microsyringe
            Development Fund (ERDF) in the framework of the project   based fabrication of high resolution organic structures for
            (BIOSIMPRO. IB20158) with the code 2021/00110/001.    bioengineering applications. Proceedings of the First Annual
                                                                  International IEEE-EMBS Special Topic Conference on
            Conflict of interest                                  Microtechnologies in Medicine and Biology, 141–145.
                                                               6.   Quirk RA, Briggs D, Davies MC, et al., 2001, Characterization
            The authors declare no conflicts of interest.         of the spatial distributions of entrapped polymers following


            Volume 9 Issue 4 (2023)                        376                         https://doi.org/10.18063/ijb.742
   379   380   381   382   383   384   385   386   387   388   389